ArticlePoultry science2025
Effects of dietary lysozyme supplementation on growth performance, intestinal morphology, immune function, antioxidant capacity, and gut microbiota in broilers.
Article in Poultry science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Intestinal Microbiota Structure of Xichuan Black-Bone Chickens and Preliminary Evaluation of a Probiotic-Based Fecal Microbiota Substitute.Microorganisms · 2026Article
- Article
- Combined supplementation with isochlorogenic acid and quercetagetin ameliorates dexamethasone-induced intestinal injury via attenuation of oxidative stress and inflammation.Frontiers in veterinary science · 2026Article
- Lysozyme and Bacillus subtilis improve growth performance, nutrient utilization, physiological stress indices, intestinal integrity, and gene expression of heat-stressed broilers.Scientific reports · 2025Article
- Effect of lysozyme supplementation on growth performance, immune status, antioxidant function and intestinal microbiota in broilers.Poultry science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study was conducted to investigate the effects of dietary lysozyme (LZ) on growth performance, intestinal morphology, immune function, antioxidant capacity, and gut microbiota in broiler chickens. A total of 360 one-day-old yellow-feathered broilers were randomly assigned to three dietary treatments: basal diet (CON) or supplemented with 250 mg/kg lysozyme (LZ250) or 500 mg/kg lysozyme (LZ500) for 56 days. Results showed that LZ, particularly LZ250, significantly enhanced the growth performance with the higher body weight (BW), and average daily weight gain (ADG), and the lower feed-to-gain ratio (F:G) (P < 0.05). Supplementation with LZ markedly enhanced the intestinal mucosal barrier by increasing the villus height and villus height-to-crypt depth ratio (VH/CD) (P < 0.05), and reducing the crypt depth in the ileum and jejunum (P < 0.05). Furthermore, LZ supplementation regulated the intestinal injury genes (Villin, MMP3, I-FABP) and promoted the expression of tight junction proteins (Occludin, Claudin-1) (P < 0.05). Serum immunoglobulins (IgA, IgM, IgY) were significantly increased by LZ (P < 0.05), while the serum inflammatory factors (IL-1β, IL-6, TNF-α) showed no significance (P > 0.05). In ileum mucosa, LZ500 significantly decreased TNF-α but increased IL-6 (P < 0.05). In addition, LZ activated the NLRP3 inflammasome via the NF-κB pathway by increasing TLR4, MYD88, IRAK4, NF-κB, NLRP3, and Caspase-1 levels. Moreover, LZ enhanced antioxidant capacity, as the evidenced by increasing superoxide dismutase (SOD) and decreasing malondialdehyde (MDA) (P < 0.05). Lysozyme increased the volatile fatty acid (VFA) levels, with LZ250 group showing significant increases in propionic and isobutyric acids and LZ500 group in isobutyric and isovaleric acids. 16S RNA sequencing showed LZ improved microbiota abundance and diversity by upregulating Romboutsia, Blautia, and Lactobacillus (P < 0.05) while decreasing Rikenellaceae (P < 0.05). In summary, dietary with lysozyme improved growth performance, gut barriers, antioxidant capacity, immune functions, and optimized the intestinal microbiota, providing its potential application in poultry production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.